{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:34:25Z","timestamp":1742949265879,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071634943"},{"type":"electronic","value":"9781071634950"}],"license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3495-0_6","type":"book-chapter","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T09:05:22Z","timestamp":1701248722000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vivo Quantitative Assessment of Gestational Choriocarcinoma Development and Progression Using Luminescent Trophoblast Cells"],"prefix":"10.1007","author":[{"given":"Wael","family":"Traboulsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Abi Nahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sergent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Alfaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Benharouga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"11","key":"6_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11912-014-0408-y","volume":"16","author":"FE Froeling","year":"2014","unstructured":"Froeling FE, Seckl MJ (2014) Gestational trophoblastic tumours: an update for 2014. Curr Oncol Rep 16(11):408","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"6_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1055\/s-0035-1558054","volume":"75","author":"FT Stevens","year":"2015","unstructured":"Stevens FT et al (2015) Gestational trophoblastic disorders: an update in 2015. Geburtshilfe Frauenheilkd 75(10):1043\u20131050","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"Suppl 3","key":"6_CR3","first-page":"S208","volume":"19","author":"H Boufettal","year":"2014","unstructured":"Boufettal H et al (2014) Gestational choriocarcinoma at Ibn Rochd Hospital, Casablanca, 2004\u20132010. East Mediterr Health J 19(Suppl 3):S208\u2013S212","journal-title":"East Mediterr Health J"},{"issue":"11","key":"6_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S1297-9589(02)00456-3","volume":"30","author":"CT Cisse","year":"2002","unstructured":"Cisse CT et al (2002) Choriocarcinoma in Senegal: epidemiology, prognosis and prevention. Gynecol Obstet Fertil 30(11):862\u2013869","journal-title":"Gynecol Obstet Fertil"},{"issue":"11","key":"6_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1470-2045(03)01245-2","volume":"4","author":"A Altieri","year":"2003","unstructured":"Altieri A et al (2003) Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4(11):670\u2013678","journal-title":"Lancet Oncol"},{"issue":"3","key":"6_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00003081-200309000-00006","volume":"46","author":"HO Smith","year":"2003","unstructured":"Smith HO (2003) Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol 46(3):541\u2013556","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"6_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ygyno.2015.01.530","volume":"137","author":"P Savage","year":"2015","unstructured":"Savage P et al (2015) Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome. Gynecol Oncol 137(1):73\u201376","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ygyno.2006.02.038","volume":"102","author":"K Foulmann","year":"2006","unstructured":"Foulmann K et al (2006) What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence. Gynecol Oncol 102(1):103\u2013110","journal-title":"Gynecol Oncol"},{"issue":"10","key":"6_CR9","first-page":"773","volume":"51","author":"JR Lurain","year":"2006","unstructured":"Lurain JR, Singh DK, Schink JC (2006) Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 51(10):773\u2013776","journal-title":"J Reprod Med"},{"issue":"10","key":"6_CR10","first-page":"767","volume":"51","author":"JR Lurain","year":"2006","unstructured":"Lurain JR, Singh DK, Schink JC (2006) Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med 51(10):767\u2013772","journal-title":"J Reprod Med"},{"issue":"10","key":"6_CR11","first-page":"785","volume":"51","author":"MS Cagayan","year":"2006","unstructured":"Cagayan MS, Lu-Lasala LR (2006) Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: a 12-year review at the Philippine General Hospital. J Reprod Med 51(10):785\u2013792","journal-title":"J Reprod Med"},{"issue":"6","key":"6_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1521-6934(03)00091-9","volume":"17","author":"JT Soper","year":"2003","unstructured":"Soper JT (2003) Role of surgery and radiation therapy in the management of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 17(6):943\u2013957","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"6_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.7150\/ijbs.1.67","volume":"1","author":"AC Bibby","year":"2005","unstructured":"Bibby AC, Litchfield DW (2005) The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta. Int J Biol Sci 1(2):67\u201379","journal-title":"Int J Biol Sci"},{"issue":"2","key":"6_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/ncb3465","volume":"19","author":"G Fluegen","year":"2017","unstructured":"Fluegen G et al (2017) Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol 19(2):120\u2013132","journal-title":"Nat Cell Biol"},{"issue":"7\u20138","key":"6_CR15","first-page":"317","volume":"55","author":"S Sasaki","year":"2010","unstructured":"Sasaki S, Sasaki Y, Iino K (2010) Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report. J Reprod Med 55(7\u20138):317\u2013320","journal-title":"J Reprod Med"},{"issue":"3","key":"6_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cub.2016.11.057","volume":"27","author":"S Lehmann","year":"2017","unstructured":"Lehmann S et al (2017) Hypoxia induces a HIF-1-dependent transition from collective-to-amoeboid dissemination in epithelial cancer cells. Curr Biol 27(3):392\u2013400","journal-title":"Curr Biol"},{"issue":"2","key":"6_CR17","first-page":"252","volume":"10","author":"R Abi Nahed","year":"2022","unstructured":"Abi Nahed R et al (2022) Role of NLRP7 in normal and malignant trophoblast cells. Biomedicine 10(2):252","journal-title":"Biomedicine"},{"issue":"12","key":"6_CR18","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3390\/cancers13122999","volume":"13","author":"D Reynaud","year":"2021","unstructured":"Reynaud D et al (2021) NLRP7 promotes choriocarcinoma growth and progression through the establishment of an immunosuppressive microenvironment. Cancers (Basel) 13(12):2999","journal-title":"Cancers (Basel)"},{"issue":"22","key":"6_CR19","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1158\/1078-0432.CCR-17-0811","volume":"23","author":"W Traboulsi","year":"2017","unstructured":"Traboulsi W et al (2017) Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo. Clin Cancer Res 23(22):7130\u20137140","journal-title":"Clin Cancer Res"}],"container-title":["Methods in Molecular Biology","Trophoblasts"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3495-0_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T09:08:35Z","timestamp":1701248915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3495-0_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"ISBN":["9781071634943","9781071634950"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3495-0_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"30 November 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}